WebNov 29, 2024 · In connection with the financing, Rachel Mears (Partner at Jeito Capital), Jeffrey Long-McGie (Managing Director at Ridgeback Capital) and Houman Ashrafian (Managing Partner at SV Health Investors ... WebMar 7, 2024 · Rachel Mears, Partner at Jeito Capital added: “One of the pillars of our investment strategy is to deploy capital in truly differentiated and innovative therapies …
Rachel Mears - Partner at Jeito The Org
WebNov 24, 2024 · Ms. Rachel Mears serves as Partner at Jeito. She also serves as Board Member at Innoskel, HIBio, Neogene and Quell Therapeutics. Over 18 years of experience … WebRachel Mears Investor - Jeito New York, NY. Jeito.life, +4 more Rachel Mears Senior Manager, State and Local Tax Greater Chicago Area. Hilco Global, +6 more ... peerless faucet cartridge rp54801
Rachel Mears on LinkedIn: #jeitocapital #privateequity …
WebMar 7, 2024 · Rachel Mears, Partner at Jeito Capital added: “One of the pillars of our investment strategy is to deploy capital in truly differentiated and innovative therapies with high unmet medical need. WebNov 29, 2024 · Rachel Mears, Partner at Jeito Capital, will join Quell’s Board of Directors. Quell is harnessing the full power of Tregs, known as the “master modulators” of immune homeostasis, to create novel cell therapies designed to suppress overactive immune responses, drive long-term tolerance in the local immune environment and promote tissue … WebExcited to share Jeito’s co-leadership for EyeBio’s Series A round and to support this great company and pioneering team working to bring innovative therapies… meat beaters band